Advertisement
Screener

Bionano Genomics, Inc. (BNGO) Increase (Decrease) in Prepaid Expense and Other Assets

Bionano Genomics, Inc. Increase (Decrease) in Prepaid Expense and Other Assets

Bionano Genomics, Inc. (BNGO) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$313.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-10

  • Bionano Genomics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $26.00K, a 10.34% decline year-over-year.
  • Bionano Genomics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$339.00K.
  • Bionano Genomics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$173.00K.
  • Bionano Genomics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $2.28M, a 188.61% increase year-over-year.
  • Bionano Genomics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $2.06M.
  • Bionano Genomics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$1.58M.
  • Bionano Genomics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$1.21M, a 137.94% decline from fiscal 2022.
  • Bionano Genomics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $3.20M, a 141.47% increase from fiscal 2021.
Period endIncrease (Decrease) in Prepaid Expense and Other Assets 3 monthIncrease (Decrease) in Prepaid Expense and Other Assets 3 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 6 monthIncrease (Decrease) in Prepaid Expense and Other Assets 6 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 9 monthIncrease (Decrease) in Prepaid Expense and Other Assets 9 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 12 monthIncrease (Decrease) in Prepaid Expense and Other Assets 12 month as first filed
2026-06-30$26.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10
-$313.00K
10-Q · filed 2026-08-10
-$486.00K
derived: sum of 3 quarters · filed 2026-08-10
$1.79M
derived: sum of 4 quarters · filed 2026-08-10
2026-03-31-$339.00K
10-Q · filed 2026-05-13
-$512.00K
derived: sum of 2 quarters · filed 2026-05-13
$1.77M
derived: sum of 3 quarters · filed 2026-05-13
$1.80M
derived: sum of 4 quarters · filed 2026-08-10
2025-12-31-$173.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23
$2.11M
derived: sum of 2 quarters · filed 2026-03-23
$2.14M
derived: sum of 3 quarters · filed 2026-08-10
$2.06M
10-K · filed 2026-03-23
2025-09-30$2.28M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$2.31M
derived: sum of 2 quarters · filed 2026-08-10
$2.23M
10-Q · filed 2025-11-13
$991.00K
derived: sum of 4 quarters · filed 2026-08-10
2025-06-30$29.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10
-$45.00K
10-Q · filed 2026-08-10
-$1.29M
derived: sum of 3 quarters · filed 2026-08-10
-$499.00K
derived: sum of 4 quarters · filed 2026-08-10
2025-03-31-$74.00K
10-Q · filed 2026-05-13
-$1.32M
derived: sum of 2 quarters · filed 2026-05-13
-$528.00K
derived: sum of 3 quarters · filed 2026-05-13
-$584.00K
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31-$1.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23
-$454.00K
derived: sum of 2 quarters · filed 2026-03-23
-$510.00K
derived: sum of 3 quarters · filed 2026-03-23
-$1.58M
10-K · filed 2026-03-23
2024-09-30$790.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$734.00K
derived: sum of 2 quarters · filed 2025-11-13
-$339.00K
10-Q · filed 2025-11-13
-$176.00K
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30-$56.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
-$1.13M
10-Q · filed 2025-08-14
-$966.00K
derived: sum of 3 quarters · filed 2025-08-14
-$557.00K
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31-$1.07M
10-Q · filed 2025-05-14
-$910.00K
derived: sum of 2 quarters · filed 2025-05-14
-$501.00K
derived: sum of 3 quarters · filed 2025-05-14
-$1.81M
derived: sum of 4 quarters · filed 2025-05-14
2023-12-31$163.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
$572.00K
derived: sum of 2 quarters · filed 2025-03-31
-$742.00K
derived: sum of 3 quarters · filed 2025-03-31
-$1.21M
10-K · filed 2025-03-31
2023-09-30$409.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14
-$905.00K
derived: sum of 2 quarters · filed 2024-11-14
-$1.38M
10-Q · filed 2024-11-14
-$1.57M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30-$1.31M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
-$1.78M
10-Q · filed 2024-08-07
-$1.98M
derived: sum of 3 quarters · filed 2024-08-07
$1.69M
derived: sum of 4 quarters · filed 2024-08-07
2023-03-31-$471.00K
10-Q · filed 2024-05-08
-$661.00K
derived: sum of 2 quarters · filed 2024-05-08
$3.00M
derived: sum of 3 quarters · filed 2024-05-08
$2.40M
derived: sum of 4 quarters · filed 2024-05-08
2022-12-31-$190.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05
$3.47M
derived: sum of 2 quarters · filed 2024-03-05
$2.87M
derived: sum of 3 quarters · filed 2024-03-05
$3.20M
10-K · filed 2024-03-05
2022-09-30$3.66M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08
$3.06M
derived: sum of 2 quarters · filed 2023-11-08
$3.39M
10-Q · filed 2023-11-08
$3.44M
10-Q · filed 2022-11-03
$2.64M
derived: sum of 4 quarters · filed 2023-11-08
2022-06-30-$600.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
-$277.00K
10-Q · filed 2023-08-09
-$186.00K
10-Q · filed 2022-08-04
-$1.02M
derived: sum of 3 quarters · filed 2023-08-09
$1.45M
derived: sum of 4 quarters · filed 2023-08-09
2022-03-31$323.00K
10-Q · filed 2023-05-09
$371.00K
10-Q · filed 2022-05-05
-$425.00K
derived: sum of 2 quarters · filed 2023-05-09
$2.05M
derived: sum of 3 quarters · filed 2023-05-09
$598.00K
derived: sum of 4 quarters · filed 2023-05-09
2021-12-31-$748.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09
$1.72M
derived: sum of 2 quarters · filed 2023-03-09
$275.00K
derived: sum of 3 quarters · filed 2023-03-09
$1.32M
10-K · filed 2023-03-09
$1.97M
10-K · filed 2022-03-01
2021-09-30$2.47M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
$1.02M
derived: sum of 2 quarters · filed 2022-11-03
$2.07M
10-Q · filed 2022-11-03
$2.50M
derived: sum of 4 quarters · filed 2022-11-03
2021-06-30-$1.45M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
-$400.00K
10-Q · filed 2022-08-04
$33.00K
derived: sum of 3 quarters · filed 2022-08-04
$843.00K
derived: sum of 4 quarters · filed 2022-08-04
2021-03-31$1.05M
10-Q · filed 2022-05-05
$1.48M
derived: sum of 2 quarters · filed 2022-05-05
$2.29M
derived: sum of 3 quarters · filed 2022-05-05
$2.10M
derived: sum of 4 quarters · filed 2022-05-05
2020-12-31$433.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$1.24M
derived: sum of 2 quarters · filed 2022-03-01
$1.05M
derived: sum of 3 quarters · filed 2022-03-01
$999.00K
10-K · filed 2022-03-01
$999.19K
10-K · filed 2021-03-23
2020-09-30$810.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$619.00K
derived: sum of 2 quarters · filed 2021-11-04
$566.00K
10-Q · filed 2021-11-04
$909.05K
derived: sum of 4 quarters · filed 2021-11-04
2020-06-30-$191.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04
-$244.00K
10-Q · filed 2021-08-04
$99.05K
derived: sum of 3 quarters · filed 2021-08-04
$289.05K
derived: sum of 4 quarters · filed 2021-08-04
2020-03-31-$53.00K
10-Q · filed 2021-05-13
$290.05K
derived: sum of 2 quarters · filed 2021-05-13
$480.05K
derived: sum of 3 quarters · filed 2021-05-13
-$608.95K
derived: sum of 4 quarters · filed 2021-05-13
2019-12-31$343.05K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23
$533.05K
derived: sum of 2 quarters · filed 2021-03-23
-$555.95K
derived: sum of 3 quarters · filed 2021-03-23
$245.05K
10-K · filed 2021-03-23
2019-09-30$190.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13
-$899.00K
derived: sum of 2 quarters · filed 2020-11-13
-$98.00K
10-Q · filed 2020-11-13
-$98.10K
10-Q · filed 2019-11-07
-$526.27K
derived: sum of 4 quarters · filed 2020-11-13
2019-06-30-$1.09M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13
-$288.00K
10-Q · filed 2020-08-13
-$287.65K
10-Q · filed 2019-08-08
-$716.27K
derived: sum of 3 quarters · filed 2020-08-13
-$1.14M
derived: sum of 4 quarters · filed 2020-08-13
2019-03-31$801.00K
10-Q · filed 2020-06-18
$801.30K
10-Q · filed 2019-05-09
$372.73K
derived: sum of 2 quarters · filed 2020-06-18
-$48.37K
derived: sum of 3 quarters · filed 2020-06-18
-$24.77K
derived: sum of 4 quarters · filed 2020-06-18
2018-12-31-$428.27K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10
-$849.37K
derived: sum of 2 quarters · filed 2020-03-10
-$825.77K
derived: sum of 3 quarters · filed 2020-03-10
-$152.01K
10-K · filed 2020-03-10
2018-09-30-$421.10K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
-$397.50K
derived: sum of 2 quarters · filed 2019-11-07
$276.26K
10-Q · filed 2019-11-07
-$253.26K
derived: sum of 4 quarters · filed 2019-11-07
2018-06-30$23.60K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
$697.36K
10-Q · filed 2019-08-08
$167.84K
derived: sum of 3 quarters · filed 2019-08-08
2018-03-31$673.76K
10-Q · filed 2019-05-09
$144.24K
derived: sum of 2 quarters · filed 2019-05-09
2017-12-31-$529.52K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14
-$770.55K
10-K · filed 2019-03-14
2017-09-30-$241.03K
10-Q · filed 2018-11-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
ASTROTECH Corp (ASTC)United States$0.013B
HARVARD BIOSCIENCE INC (HBIO)United States$0.037B-2.70
Precipio, Inc. (PRPO)United States$0.043B-36.70
Seer, Inc. (SEER)United States$0.104B-1.34
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Quanterix Corp (QTRX)United States$0.150B-1.65
EyePoint, Inc. (EYPT)United States$0.314B-3.96
908 Devices Inc. (MASS)United States$0.476B-9.53
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15